Survival from testicular cancer in England and Wales up to 2001

Por Huddart, R A
Publicado em 2008

Changes in BMI after treatment of testicular cancer are due to age and hormonal function and not chemotherapy

Por Huddart, R A, Norman, A
Publicado em 2003

Familial predisposition to both male and female germ cell tumours?

Por Huddart, R A, Thompson, C, Houlston, R, Huddart, R A, Nicholls, E J, Horwich, A
Publicado em 1996

Screening for testicular cancer. Familial predisposition ignored.

Por Huddart, R. A., Leahy, M. G.
Publicado em 1994

Microsatellite instability in human testicular germ cell tumours.

Por Huddart, R. A., Wooster, R., Horwich, A., Cooper, C. S.
Publicado em 1995

Pre-treatment nomogram for biochemical control after neoadjuvant androgen deprivation and radical radiotherapy for clinically localised prostate cancer

Por Parker, C C, Norman, A R, Huddart, R A, Horwich, A, Dearnaley, D P
Publicado em 2002

The utility of tumour markers in assessing the response to chemotherapy in advanced bladder cancer

Por Cook, A M, Huddart, R A, Jay, G, Norman, A, Dearnaley, D P, Horwich, A
Publicado em 2000

The prevalence of avascular necrosis in patients treated with chemotherapy for testicular tumours

Por Cook, A M, Dzik-Jurasz, A S K, Padhani, A R, Norman, A, Huddart, R A
Publicado em 2001

Fertility, gonadal and sexual function in survivors of testicular cancer

Por Huddart, R A, Norman, A, Moynihan, C, Horwich, A, Parker, C, Nicholls, E, Dearnaley, D P
Publicado em 2005

Fluorodeoxyglucose positron emission tomography in the evaluation of germ cell tumours at relapse

Por Hain, S F, O’Doherty, M J, Timothy, A R, Leslie, M D, Harper, P G, Huddart, R A
Publicado em 2000

Evidence-based pragmatic guidelines for the follow-up of testicular cancer: optimising the detection of relapse

Por van As, N J, Gilbert, D C, Money-Kyrle, J, Bloomfield, D, Beesley, S, Dearnaley, D P, Horwich, A, Huddart, R A
Publicado em 2008

Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects

Por Dearnaley, D P, Hall, E, Lawrence, D, Huddart, R A, Eeles, R, Nutting, C M, Gadd, J, Warrington, A, Bidmead, M, Horwich, A
Publicado em 2005

Testicular microlithiasis as a familial risk factor for testicular germ cell tumour

Por Coffey, J, Huddart, R A, Elliott, F, Sohaib, S A, Parker, E, Dudakia, D, Pugh, J L, Easton, D F, Bishop, D T, Stratton, M R, Rapley, E A
Publicado em 2007

High activity Rhenium-186 HEDP with autologous peripheral blood stem cell rescue: a phase I study in progressive hormone refractory prostate cancer metastatic to bone

Por O'Sullivan, J M, McCready, V R, Flux, G, Norman, A R, Buffa, F M, Chittenden, S, Guy, M, Pomeroy, K, Cook, G, Gadd, J, Treleaven, J, Al-Deen, A, Horwich, A, Huddart, R A, Dearnaley, D P
Publicado em 2002

Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer

Por Beyer, J., Albers, P., Altena, R., Aparicio, J., Bokemeyer, C., Busch, J., Cathomas, R., Cavallin-Stahl, E., Clarke, N. W., Claßen, J., Cohn-Cedermark, G., Dahl, A. A., Daugaard, G., De Giorgi, U., De Santis, M., De Wit, M., De Wit, R., Dieckmann, K. P., Fenner, M., Fizazi, K., Flechon, A., Fossa, S. D., Germá Lluch, J. R., Gietema, J. A., Gillessen, S., Giwercman, A., Hartmann, J. T., Heidenreich, A., Hentrich, M., Honecker, F., Horwich, A., Huddart, R. A., Kliesch, S., Kollmannsberger, C., Krege, S., Laguna, M. P., Looijenga, L. H. J., Lorch, A., Lotz, J. P., Mayer, F., Necchi, A., Nicolai, N., Nuver, J., Oechsle, K., Oldenburg, J., Oosterhuis, J. W., Powles, T., Rajpert-De Meyts, E., Rick, O., Rosti, G., Salvioni, R., Schrader, M., Schweyer, S., Sedlmayer, F., Sohaib, A., Souchon, R., Tandstad, T., Winter, C., Wittekind, C.
Publicado em 2013